Please assess the completion status of the following clinical trial:

Trial Title: Study of Ocular Penetration of Topically Administered Fluoroquinolones

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who have a visually significant cataract and are planning to have cataract surgery.~* Subjects who are willing/able and have signed informed consent approved by the Institutional Review Board.~Exclusion Criteria:~* Subjects who have a known hypersensitivity, allergy, or contraindication to any fluoroquinolone medication, in any form.~* Subjects who signs of ocular infection or active inflammation in the study eye.~* Subjects who have corneal pathology, including epithelial defect, corneal scarring, or severe dry eye syndrome.~* Subjects who have used any disallowed medication (including antibiotics) during the time period designated as described in the protocol.~* Subjects who have any active or chronic/recurrent ocular or systemic disease that is uncontrolled and is likely to increase the risk of infection to the patient or confound the results of the study.~* Subjects who are pregnant (or suspect to be pregnant) or nursing/lactating.~* Subjects who have participated in any study of an investigational drug or device within 30 days prior to enrollment.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Moxifloxacin 0.5% ophthalmic solution (Type: ACTIVE_COMPARATOR): None
- Besifloxacin 0.6% ophthalmic suspension (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).